Cell surface molecules that regulate antigen-dependent signaling of T cells have been the focus of much investigation. Data have emerged indicating that the clonotypic a/0 heterodimer, expressed on the surface of T cells in association with the lineage-specific CD3-protein complex, recognizes antigen in the context of MHC gene products expressed on the surface ofantigen-presenting (accessory) cells (1-5). Additional T cell surface molecules, the CD41 and the CD8 antigens, appear to contribute to the T cell activation process by functioning as associative recognition/restriction elements for the monomorphic component of MHC antigens . Although the CD2 antigen has also been implicated in many aspects of T cell functions, its role in T cell activation initiated via the CD3/TCRa/(3 is controversial (6-12) .
Measurement of T Cell Activation . IL-2 receptor a (CD25) expression was measured by FAGS analysis using Epics C cell sorter (Coulter Corp.), as described (18) . The cells were labeled with PE-conjugated anti-CD25 mAb and the percentage of cells expressing IL-2 receptor a was determined by analysis of immunofluorescence histograms, with Epics C multidata acquisition and display systems, software version 3.1. PE-conjugated isotypic control mAb was used to determine nonspecific fluorescence signal .
T cell proliferation was quantitated by determining [3H]thymidine incorporation. In brief, T cells, CD4+ or CD8* T cells (106 cells/ml) were cultured in a total volume of 200 A1 in round-bottomed microwell plates at 37°C in a 5% C02, 95% air humidified atmosphere and [3H]thymidine incorporation into DNA during 48-64 h of culture was determined in a liquid scintillation counter. T cells were cultured in RPMI medium 1640 (catalogue no. 380-2400, Gibco Laboratories, Grand Island, NY) supplemented with 5% FCS (catalogue no. 230-6140, Gibco Laboratories) and 0.1% gentamycin .
Measurement of Intracellularfree Cat' Concentration . Intracellular free Cat`concentration of T cells was determined using indo-1 (Molecular Probes, junction, City, OR), as described (18) . In brief, T cells were incubated with acetoxy-methyl ester of indo-1 (10 AM, 90 min, 37°C), washed thrice, and resuspended at 106 cells/ml in the buffer medium . The ratio of 398 (violet)/482(blue) fluorescence ofindo-1 loaded T cells was measured'at designated time intervals (R) and after lysis of cells with 1% Triton X-100 in the absence (Rm.) or presence of 10 mM EGTA (Rmi), using a LS-5 Perkin-Elmer spectrofluorometer (Perkin-Elmer, Long Island, NY) . Cat* concentration was calculated using the formula: [Ca2'] = Kd x (RRmin)/(Rm. + R) x sf2/sb2, where Kd is the dissociation constant (250 nM) and sf2/sb2 is the ratio of the blue fluorescence intensity of the Ca 2 +-free and bound dye, respectively (18) .
Detection of IL-2 Gene Activation by Polymerase Chain Reaction (PCR). A new methodology, reverse transcription followed by PC R (20) , was utilized for the detection ofWRNA encoding IL-2 . In brief, total cellular RNA, isolated from T cells by guanidinium isothiocyanate/cesium chloride method, was reverse transcribed into cDNA with 0.1 p.g/ml oligo(dT) primers and 200 U ofMoloney murine leukemia virus (M-MLV) reverse transcriptase (Bethesda Research Corp., Bethesda, MD) . The first strand cDNA copies were then amplified (30 cycles) with either an IL-2 sequence specific primer pair (5'-CCTCTGGAGGAAGTGCTAAA-3' and 5'-ATGGTTGCTGTCTCATCAGC-3') or o fl-actin sequence specific primer pair (5'-GTGG-GCCGCTCTAGGCACCA-3'and 5'-TGGCCTTAGGGTGCAGGGGG-3') and Thermus aquaticus DNA polymerase (Taq polymerase, Perkin-Elmer/Cetus Corp.), using a DNA thermal cycler (Gene Machine; USA/Scientific Plastics, Ocala, FL) . The amplification profile consisted of denaturation at 95°C for 45 s, primer annealing at 55°C for 1 min, and extension at 72°C for 1 min. The PCRgenerated products were fractionated by agarose gel electrophoresis, and validated by the predicted size of the amplified cDNA fragments and by restriction enzyme analysis.
Results
Synergism between mAbs Directed at the 71C'R and CD2 Antigen. We examined whether antiTCR 1 and anti-CD2 mAbs are synergistic in promoting T cell proliferation. This experimental approach was prompted by: (a) the observation that the mitogenic activity of antiTCR1, a mAb that reacts with a framework determinant of CD3/TCRa/a for antigen, is fully dependent upon the presence ofmonocytes (15) (16) (17) , and (b) our earlier demonstration that the crosslinked anti-CD2 can function as an effective substitute for monocytes in oxidative mitogenesis (14) . Fig. 1 illustrates that OKT11, a prototypic mAb directed at the SRBC-binding epitope of CD2 antigen (21) , and antiTCRl are indeed synergistic in promoting T cell proliferation: [sH]thymidine incorporation was only 1,395 t 501 cpm/culture with T cells incubated alone, and it increased significantly to 102,070 t 7,733 cpm/culture when T cells were simultaneously signaled with antiTCR1 and OKT11 (mean t SEM, n = 8, p < 0.0001, ANOVA). It is important to note that the marked proliferative response is absolutely dependent upon crosslinking of antiTCR1 with OKT11 and that neither the combined presence of soluble phase antiTCR1 and OKT11 nor the crosslinking of antiTCR-1 alone or crosslinking of OKT11 alone promotes T cell proliferation (Fig . 1 A) .
Several additional features of the synergism between antiTCRl and OKT11 are also illustrated in Fig. 1 : (a) specificity of synergism: whereas antiTCR1 and OKT11 are synergistic, neither mAb is synergistic with soluble phase or crosslinked antiLeu-1 (anti-CD5) mAb (Fig. 1 B) , (b) the need for crosslinking antiTCR1 with OKT11: whereas crosslinking antiTCRl with OKTll induces marked proliferation, selective crosslinking of antiTCR1 (with affinity-purified antibodies specific for mouse IgG1) fails to induce significant proliferation of T cells treated with soluble phase OKT11, and selective crosslinking of OKT11 (with affinity-purified antibodies specific for mouse IgG2a) fails to elicit marked proliferation of T cells treated with soluble phase anti TCR1 . Furthermore, selective but independent crosslinking of antiTCR1 and OKT11 does not induce T cell proliferation ( Fig. 1 C) , and (c) dose-response characteristics: the magnitude of T cell proliferation elicited with crosslinked anti-TCR1 and OKT11 is dependent upon the concentrations of antiTCR1 as well as OKT11 (Fig. 1, D 
and E) .
Synergism between F(ab')2 Fragments ofmAbs Directed at the TCR and CD2 Antigen. In a fashion analogous to the signaling activity of intact antiTCR1 and OKT11, F(ab')2 fragments of antiTCR1 and OKT11 were clearly synergistic in stimulating T cells. Fig. 1 F illustrates the marked proliferation resulting from stimulating T cells with F(ab')2 antiTCR1, F(ab')2 OKT11, and F(ab')2 rabbit anti-mouse IgG. Fig. 1 F shows also that neither the combined presence of soluble phase F(ab')2 anti-TCR1 and F(ab')2 OKT11 nor crosslinking of F(ab')2 antiTCRl alone or F(ab')2 OKTll alone induces marked proliferation of T cells. The stimulation indices ([3H]thymidine incorporation of treated T cells/[3H]thymidine incorporation of untreated T cells) were 137 with T cells treated with F(ab')2 antiTCR1 (0.25 kg/ml), F(ab')2 OKT11 (0.5 Wg/ml), and F(ab')2 rabbit anti-mouse IgG (RaM IgG 2.5 Wg/ml) ; 1.3 with T cells treated with crosslinked F(ab')2 OKT11 alone; 1.2 with T cells treated with crosslinked F(ab')2 antiTCR-1 alone; and 1 .6 with T cells treated with soluble phase F(ab')2 OKTll and F(ab')2 antiTCR1.
The magnitude ofT cell proliferation was influenced not only by the relative concentrations of F(ab')2 fragments of RaM IgG (Fig . 1 F) but also by the concentrations of F(ab')2 fragments of mAbs . For example, treatment of T cells with F(ab')2 OKT11 (1.0 lAg/ml), F(ab')2 RuM IgG (2.5 ttg/ml), and 0.06, 0.125, 0.25, or 0.50 Wg/ml of F(ab')2 antiTCR-1 resulted in stimulation indices of 8, 31, 48, and 90, respectively.
Anti-MR-1 and Anti-CD2 Are Synergistic in Inducing Proliferation of CD4' T Cells and CD8' T Cells. Data summarized in Fig. 1 demonstrate that the crosslinkage of TCR with CD2 antigen promotes T cell proliferation independent ofco-stimulatory signals (e.g., accessory cells, exogenous cytokines or phorbol esters). It was of interest to determine whether this novel method of activation is effective in each of the two major subsets of T cells, the CD4' and CD8' T cells. Crosslinked antiTCR1 and anti-CD2 did induce significant proliferation ofhighly purified CD4+ subset and the CD8+ subset of T cells. AntiTCR1 or anti-CD2, however, did not synergize with anti-CD4 or anti-CD8 mAbs and induce proliferation, under similar experimental conditions. The stimulation indices ([3H]thymidine incorporation of CD4+ or CD8+ T cells treated with crosslinked mAbs/[3H]thymidine incorporation of untreated CD4+ or CD8+ T cells) were 264, 4, 1.4, and 0.7 when CD4+ T cells were treated with crosslinked anti TCR1 (0.125 Rg/ml) and anti-CD2 (OKT11, 0.5 hg/ml), crosslinked antiTCR1 and anti-CD4 (OKT4A, 0.5 wg/ml), crosslinked anti-CD2 and anti-CD4 (OKT4A), or crosslinked anti-CD2 and anti-CD4 (OKT4, 0.5 ug/ml), respectively. The stimulation indices were 225, 2, and 1 when CD8 + T cells were treated with crosslinked antiTCR1 and anti-CD2, crosslinked antiTCRl and anti-CD8 (OKT8, 0.5 ttg/ml), or crosslinked anti-CD2 and anti-CD8 mAbs, respectively. Also, simultaneous but independent crosslinking of TCR and the CD2 antigen on the surface of CD4+ T cells or CD8+ T cells did not result in marked proliferation of either subset : the stimulation indices were only 0 .8 and 1.3 when CD4+ T cells and CD8 + T cells, respectively, were treated with anti-TCR-1 (0.125 ug/ml), OKT11 (0.5 tag/ml), gaM IgGl and gaM IgG2a (2.5 ttg/ml, each). Thus, crosslinkage of TCR with CD2 antigen, and not simultaneous but independent crosslinking of TCR and CD2 antigen or crosslinking of TCR or CD2 antigen with the CD4 or the CD8 antigen, is a sufficient stimulus for the induction of proliferation of normal human CD4+ or CD8 + T cells.
Effects of Crosslinkage of 71CR and/or CD2 Antigen on Ca 21 Mobilization. An increase in the concentration of intracellular free Cat+ is considered to be an early obligatory event for T cell proliferation (22, 23) . Given that crosslinkage of TCR with the CD2 antigen promotes T cell proliferation and selective crosslinkage of TCR or CD2 antigen does not, effects of crosslinking of antiTCR1 with 0KT11 as well as effects of selective crosslinking of anti TCR1 and of 0KT11 on intracellular Ca 2+ homeostasis were determined . Fig. 2 shows a rapid and marked increase in the concentration of intracellular free Cat' by crosslinking antiTCR1 with OKT11: intracellular free Cat+ concentration increased from a precrosslinked value of201 t 8 nM to a peak value of 1,235 t 63 nM following the addition of goat anti-mouse IgG to T cells pretreated with antiTCR1 and 0KT11 (mean t SEM, n = 6, p < 0.0001, ANOVA).
Selective crosslinking ofantiTCR1 or OKTll, in the presence of reciprocal mAb in soluble phase, also resulted in an increase in the concentration of intracellular free Cat+ . However, the magnitude of increase and the kinetics of increase found with selective crosslinking were distinctly different from that found with crosslinking of OKT11 with anti TCRl. As illustrated in Fig. 2 2 . Calcium mobilization from crosslinked antiTCR1 and/or OKT11 . Intracellular free calcium concentration was determined with indo-1 loaded T-cells (10 6 cells) as described in Materials and Methods. AntiTCR l (0 .125 pg/ml) and OKT11 (0 .5 Wg/ml) were added to Tcell after determining the resting Tcell calcium concentration ; the mAbs were crosslinked with gaM IgG ( " ), gaM specific for IgGl (/) or IgG2A (A---A) . Results (mean t SEM) from six consecutive experiments (concentration of crosslinking reagent : 17 5 .0 ug/ml) .
centrations were 421 t 46 nM and 635 t 58 nM with selective crosslinking ofOKT11 or antiTCR1, respectively, in the presence of reciprocal mAb in soluble phase as compared with 1,235 t 63 nM following crosslinkage of antiTCR1 with OKT11 (p < 0.0001, ANOVA). The peak concentration was reached rapidly by crosslinking antiTCR1 with OKT11 or by selective crosslinking of antiTCR1 alone, and was reached slowly by selective crosslinking of OKT11. A sustained increase in the concentration of Cat' above the precrosslinked Cat+ value was evident by crosslinking antiTCR1 and OKT11 or by selective crosslinking of OKT11, and not from selective crosslinking of antiTCR1. Thus, crosslinking ofantiTCR1 and OKTll resulted in a Cat+ mobilization profile that included the rapid increase in the Ca 21 levels found with selective crosslinking of antiTCR1 alone and the sustained increase resulting from selective crosslinking of OKT11 alone.
E f fects offulators ofProtein Kinase C (PKC) on the Signaling of T Cells by Crosslinkage of 7LR with'-the CD2 Antigen. Ca2 + and PKC activation participate in signal transduction in a variety of eukaryotic cells (24, 25) . Having documented Cat' mobilization by crosslinking the TCR with the CD2 antigen, we investigated the role of Ca T cell proliferation induced by crosslinking antiTCR1 (0.125 pcg/ml) with OKT11 (0.5 Ag/ml) was inhibited by EGTA: dose-response experiments revealed that the half-maximal inhibitory concentration (IC5o) was 0.28 mM. The compound H-7, a derivative of isoquinolinesulfonamide and a competitive inhibitor of PKC (26), inhibited T cell proliferation and the IC5o was 0.019 mM. Staurosporine, a microbial alkaloid and a direct inhibitor ofPKC (27) , also mediated marked inhibition and the IC5o was 0.003 mM. An additional compound, K-252a, a competitive inhibitor of PKC whose mechanism of action is similar to that of compound H-7 but with a greater potency (28) , also inhibited T cell proliferation induced by crosslinkage of antiTCR-1 with OKT11 and the IC5o for K-252a was 0.05 /AM. T Cell Proliferation Induced by Crosslinkage of 7L'R with the CD2Antigen Is IL-2 Dependent. IL-2-dependent as well as IL-2-independent pathways of T cell activation have been reported (29) (30) (31) (32) . We therefore determined whether crosslinking the TCR with the CD2 antigen results in transcriptional activation and translation of the gene for IL-2. We also examined whether IL-2 receptor a (a subunit of IL-2 receptor that facilitates high-affinity binding of IL-2) is induced and whether successful interaction between IL-2 and its receptor is required for T cell proliferation elicited by crosslinking the TCR with the CD2 antigen.
Agarose gel electrophoretic analysis of PCR products generated with IL-2 sequence-specific primers or with fl-actin sequence-specific primers and Taq polymerase are illustrated in Fig. 3 . It is evident that: (a) T cells signaled with crosslinked antiTCR-1 and OKT11 express the IL-2 gene (lane 4); (b) crosslinking of antiTCR1 alone, OKT11 alone or simultaneous but independent crosslinking of antiTCR1 and of OKT11 does not result in IL-2 mRNA accumulation (lanes 2, 3, 5 and 6), and (c) a-actin mRNA (control mRNA) expression is similar in mAb treated or untreated T cells (lanes 1-6) . In accordance with the data shown in Fig.  3 , cell-free supernatants, obtained from T cells treated with crosslinked antiTCR1 and OKT11, induced marked proliferation of an IL-2-dependent cytotoxic T cell line (33) .
Signaling of T cells with crosslinked antiTCR1 and OKT11 resulted also in the induction of IL-2 receptor u expression . FAGS analyses illustrating the synergism between anti TCR1 and OKT11 in the elicitation of IL-2 receptor a expression are summarized in Fig. 4 . In a fashion homologous to physiologic signaling of T cells, the proliferative response elicited by crosslinking TCR with the CD2 antigen was dependent upon successful interactions between IL-2 and its receptor. As shown in Fig. 5 , mAb directed at IL-2 receptor u (anti-CD25 mAb) inhibited T cell proliferation induced with crosslinked anti TCR1 and OKT11 (26 < 0.001, ANOVA). The inhibition resulting from anti-CD25 mAb was reversed, in a concentration-dependent manner, by recombinant IL-2 (Fig . 5, B-E) .
Discussion
Results from this study demonstrate for the first time that crosslinkage of CD3/ TCRa//3 complex with the CD2 antigen on the surface of CD4+ or CD8+ T cells results in their activation independent ofcostimulatory signals (e.g., accessory cells, exogenous lymphokines, or phorbol esters). Furthermore, crosslinkage of TCR with the CD2 antigen elicits an activation cascade that is homologous to physiological antigenic signaling of T cells with respect to: (a) Cat + mobilization and PKC activation for cell-surface signal transduction, (6) transcriptional activation and translation of the gene for IL-2, and (c) utilization of IL-2 and IL-2 receptor pathway for the proliferative response. Several features ofour experimental design are worthy of emphasis: First, normal human resting T cells and T cell subsets and not abnormal or preactivated T cells were used in our study. This approach represents a significant physiological advantage in light of the differential signaling requirements of T cell lines, clones, or hybridomas compared with resting T cells (34) (35) (36) (37) . Second, mAbs directed at a framework determinant of the CD3/TCRcdO complex rather than mitogenic lectins were used. This strategy permits the study of the signaling activity of a cell-surface molecule involved in physiological antigen signal transduction . It is important to note that antiTCR1, at concentrations used in our study, reacts only with the T cells expressing the a//3 heterodimer of the TCR and not with T cells that do not express this heterodimer (38) . Third, mAbs directed at the CD2 antigen were used to generate the obligatory accessory signal in our investigation. Given that the CD2 antigen is expressed on all peripheral blood T cells, our approach has the potential to uncover signaling pathways operative in the CD4 as well as the CD8 subset of normal human T cells. Fourth, mAbs directed at the SRBC-binding epitope (CD2.1 epitope) of the CD2 antigen were used herein to generate the stimulatory signal . This is significant in view of earlier suggestions that the CD2.1 epitope generates inhibitory signals and that the CD2.2 and CD2.3 epitopes need to be engaged in order to generate stimulatory signals (6) (7) (8) (9) . Moreover, the CD2.1 epitope, unlike some of the other epitopes of the CD2 antigen (CD2.3 or 9-1), is constitutively expressed on resting T cells and thus has the potential to initiate and/or participate in the very first event obligatory for T cell activation . Fifth, activation was accomplished in our study in the absence of co-stimulatory agents (e.g ., feeder cells, exogenous IL-2 or tumor promoters). These additional stimuli are mandatory for T cell proliferation induced with mAb combinations such as CD2 -D66 + CD2 9.6/T11t (39), CD3-BMA030 + mAb directed at T cell surface antigens (40, 41) , or CD3-RW24B6 + CD4-19 Thy 5D7 or CD8-21 Thy 2D3 (42) .
Signaling by Crosslinkage of 7CR with the CD2 Antigen. An important requirement for the induction of proliferation of normal human T cells demonstrated herein is that the TCR should be crosslinked with the CD2 antigen: selective or simultaneous but independent crosslinking of these cell surface molecules is insufficient to elicit the proliferative response . Furthermore, crosslinkage of TCR with CD2 but not of either antigen with CD4 or CD8 antigen elicits marked proliferation (of the corresponding subset) independent of co-stimulatory signals. This differential signaling potential of T cell surface molecules, viewed especially in the light of observations (22) (23) (24) (25) 43) . Indeed, crosslinkage of the TCR with the CD2 antigen resulted in a marked and sustained increase in intracellular free Cat' levels . Our finding that a sustained increase in Cat' is required for the full activation of normal human T cells is reminiscent of the observation that a sustained but not a transient increase in intracellular free Ca 2+ is associated with the expression of the IL-2 gene inJurkat T cell line (44) . Our additional observations that EGTA and regulators of PKC are inhibitory are consistent with Caz+ mobilization and PKC activation participating in the transduction of signals generated by crosslinkage of TCR with the CD2 antigen.
Utilization of an Operational IL-2 System . Antigen-induced T cell proliferation is dependent upon the expression of receptors for IL-2, production of IL-2, and successful interaction between IL-2 and its receptors (29, 30) . Evidence for an interleukinindependent pathway for human lymphocyte proliferation however, has also been presented (31, 32) . Our data that crosslinkage of TCR with the CD2 antigen induces IL-2 gene activation and IL-2 receptor expression, and that mAb directed at the IL-2 receptor inhibits T cell proliferation, support the contention that T cell proliferation induced by this novel approach is dependent upon an operational IL-2 system, and is homologous to physiological antigen-dependent T cell proliferation.
A Novel Modelfor Antigen-dependent T Cell Signaling. A unifying theme has emerged in which T cells view antigens in the context of MHC gene products expressed on antigen-presenting (accessory) cells. T cell surface proteins, in addition to the TCR, that contribute to the informative T cell-accessory cell interactions, however, have remained an enigma despite the paradigm that the CD4 and CD8 molecules function as associative recognition/restriction elements for the MHC gene products expressed on the surface of accessory cells.
Based on our current as well as earlier investigations, it is possible to conceptualize a novel model for antigen-dependent activation of T cells. As schematized in Fig. 6 , instructive T cell-accessory cell interactions might proceed not only via molecular contacts between the TCR and the MHC-peptide but also via the CD2 antigen and the LFA-3 and/or other sites on accessory cells (step 1). These cell-surface molecular interactions then, lead to the coclustering of the TCR with the CD2 antigen (step 2). The antigen-and accessory cell-induced association between the TCR and the CD2 antigen is necessary for the optimum generation of second messenger molecules (Ca2+ , DAG, etc.) and transcriptional activation and translation of genes (IL-2, IL-2 receptor, etc.) responsible for the antigen-dependent clonal expansion of normal human T cells (step 3). A critical observation that supports the concept formulated herein is our earlier demonstration that the anti-CD2 mAb (the same Antigen-dependent T cell-accessory cell interactions involve not only molecular contacts between CD3/TCR-a/,6 complex and the antigenic peptide (") viewed in the context of MHC antigens on accessory cells but also physical associations between the CD2 antigen with LFA-3 and/or other sites (step 1). These molecular contacts lead to the redistribution and coclustering of the TCR andthe CD2 antigen on the surface of T cells (step 2) . This coclustering is required for the optimum generation of second messenger molecules and the activation of genes responsible for antigendependent clonal expansion of T cells (step 3) . mAb used in this investigation) prevents clustering between T cells and accessory cells; an important additional supportive observation from our laboratory is that anti-CD2 (soluble phase) inhibits T cell proliferation only when the obligatory costimulatory signal is provided with accessory cells but not when TPA (accessory cell substitute) provides the accessory signal (13, 14) . Elegant data showing that antigendependent IL-2 production is enhanced by the expression of CD2 antigen in a murine T cell hybridoma (45) and that LEA-3, a natural ligand for CD2 antigen (46) , is mitogenic (47) , are in accord with some of the features of the minimal model formulated here for the activation of normal human quiescent T cells.
Summary
Transmembrane signaling ofnormal human T cells was explored with mAbs directed at TCR, CD2, CD4, CD5, or CD8 antigens and highly purified CD4+ T cells and CD8+ T cells. Our experiments explicitly show that: (a) crosslinkage of TCR with the CD2 antigen, and not independent crosslinking of TCR and of CD2 antigen or crosslinking of either protein with the CD4 or CD8 antigen induces significant proliferation independent ofco-stimulatory signals (e.g., accessory cells, recombinant lymphokines, or tumor promoter), (b) F(abr)2 fragments of mAb directed at the TCR and F(abr)2 anti-CD2, crosslinked with F(abr)2 fragments of rabbit anti-mouse IgG, promote the proliferation of highly purified T cells, (c) a prompt and sustained increase in intracellular free Cat+ concentration results from crosslinkage of TCR with the CD2 antigen, (d) T cell proliferation induced by this novel approach is curtailed by EGTA and by direct or competitive inhibitors of PKC, (e) crosslinkage of TCR with the CD2 antigen results in the transcriptional activation and translation ofthe gene for IL-2 and in the expression of IL-2 receptor a (CD25), (f) anti-CD25 mAbs inhibit T cell proliferation initiated by crosslinkage of TCR with the CD2 antigen, and recombinant IL-2 restores the proliferative response . Our first demonstration that crosslinkage ofTCR with the CD2 antigen induces proliferation ofnormal human CD4+ T cells and CD8 + T cells, in addition to revealing a novel activation mechanism utilizable by the two major subsets of T cells, suggest that the CD2 antigen might be targeted for the regulation of antigen-specific T cell immunity (e.g., organ transplantation) .
